Table 1.

Top Pathways from the gene set enrichment analysis (GESA)

Pathway Names	Count	p-value	Bonferroni	FDR
Alzheimer’s disease	30	2.02E–29	2.43E–27	2.32E–26
Amyotrophic lateral sclerosis (ALS)	24	7.85E–18	9.41E–16	9.01E–15
Pathways in cancer	50	1.98E–14	2.37E–12	2.27E–11
Prostate cancer	26	4.82E–14	5.78E–12	5.53E–11
MAPK signaling pathway	39	1.20E–10	1.43E–08	1.37E–07
Neurotrophin signaling pathway	26	1.46E–10	1.75E–08	1.67E–07
Bladder cancer	16	1.52E–10	1.83E–08	1.75E–07
Calcium signaling pathway	31	1.55E–10	1.86E–08	1.78E–07
Pancreatic cancer	20	2.04E–10	2.44E–08	2.34E–07
Toll-like receptor signaling pathway	23	4.13E–10	4.96E–08	4.75E–07